Difference between revisions of "Dummer R, et al. J. Am. Acad. Dermatol (2016) cited as Ref 600 in DOI: 10.1038/s41392-020-0110-5 (Q9863)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 75, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: Page(s) (P105): 113-125, #quickstatements; #temporary_batch_1590074839150) |
||
| (One intermediate revision by the same user not shown) | |||
| Property / title | |||
| + | The 12-month analysis from basal cell carcinoma outcomes with LDE225 treatment (BOLT): a phase II randomized double-blind study of sonidegib in patients with advanced basal cell carcinoma (English) | ||
| Property / title: The 12-month analysis from basal cell carcinoma outcomes with LDE225 treatment (BOLT): a phase II randomized double-blind study of sonidegib in patients with advanced basal cell carcinoma (English) / rank | |||
| + | Normal rank | ||
| Property / Page(s) | |||
| + | 113-125 | ||
| Property / Page(s): 113-125 / rank | |||
| + | Normal rank | ||
Latest revision as of 15:46, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Dummer R, et al. J. Am. Acad. Dermatol (2016) cited as Ref 600 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Dummer R
0 references
2016
0 references
J. Am. Acad. Dermatol
0 references
75
0 references
The 12-month analysis from basal cell carcinoma outcomes with LDE225 treatment (BOLT): a phase II randomized double-blind study of sonidegib in patients with advanced basal cell carcinoma (English)
0 references
113-125
0 references
